News
Verastem (NASDAQ:VSTM – Get Free Report) had its target price upped by analysts at HC Wainwright from $7.00 ... a 12 month low of $2.10 and a 12 month high of $13.52. The company has a debt ...
Hosted on MSN2mon
H.C. Wainwright lifts Corcept stock target to $115 on drug outlookOn Tuesday, H.C. Wainwright increased its price target on ... return over the past year and currently trades near its 52-week high of $71.29. According to InvestingPro analysis, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results